The customer engagement paradigm has been evolving with HCPs’ changing preferences and the advent of digital channels. This evolution has prompted a strong focus on ensuring effective non-personal and virtual interactions rather than the traditional face-to-face coverage. The COVID-19 pandemic further accelerated this shift encouraging pharma companies to rethink their multichannel strategy to continue engaging with their customers.
Axtria surveyed leading life sciences companies to understand their customer engagement planning and execution strategy and omnichannel readiness before, during, and after the pandemic. This infographic summarizes the key findings of the survey and the corresponding insights.